Coherus BioSciences to Present at Upcoming Investor Conferences in May

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

REDWOOD CITY, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:

  • Bank of America Merrill Lynch Global Healthcare 2023 Conference in Las Vegas on Thursday, May 11, 2023; fireside chat at 10:15 a.m. PDT
  • UBS Global Healthcare Conference at UBS NY headquarters on Tuesday, May 23, 2023 for 1x1 meetings only between 8:00 a.m. and 5:00 p.m. EDT

An audio webcast of the fireside chat presentation will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.

Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
IR@coherus.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.51
-4.71 (-1.76%)
AAPL  302.30
+4.09 (1.37%)
AMD  434.85
-14.85 (-3.30%)
BAC  49.42
-0.43 (-0.85%)
GOOG  393.17
-4.00 (-1.01%)
META  613.37
-5.06 (-0.82%)
MSFT  422.23
+12.80 (3.13%)
NVDA  228.60
-7.14 (-3.03%)
ORCL  192.86
-2.75 (-1.41%)
TSLA  426.69
-16.61 (-3.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.